Vardhman Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Vardhman Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2007-12-13 New Delhi, Delhi Active Unlisted Active Non-Compliant
Share
VL Vardhman Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vardhman Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
43/100
Trust Score
Caution Indicated

Vardhman Life Sciences Private Limited is assessed as Caution Indicated with a Trust Score of 43/100. Vardhman Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2007, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 22 Jul 2026 from the latest processed filings. Vardhman Life Sciences Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
43/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
48/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 4 open (175.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Edelweiss Asset Reconstruction Company Limited3 48.0 cr
Others1 48.0 cr
Compliance Score: 48/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2015 - filings overdue.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
VIVEK GUPTA 01234567 Director 01/04/2018 6 yrs Approved
SUYOG JAIN 01234567 Director 01/04/2018 6 yrs Approved
RAJINDER SINGH GUJRAL 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • RAJINDER SINGH GUJRAL has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2015 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Vardhman Chemtech Limited
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 0 transfer(s)
Group entityRelationship% held
Vardhman Chemtech Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 30
Growth signals & trust indicators
Operating for 18+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (48/100).
4 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence41/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment32/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) of 175.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view28/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
21 Mar 2017
Last AGM held
Annual general meeting
30 Sep 2015
Director ceased
JITENDER SHARMA
Director ceased
YOGITA NARHARI JADHAV
31 Mar 2015
Latest balance sheet
Filed with ROC
09 May 2014
Director ceased
GAURAV SINGH BHANDARI
18 Apr 2013
Securities allotted
21000000 Equity Shares Without Differential Rights - 105.00 cr raised
28 Sep 2012
Director ceased
SANJAY KUMAR RANDHAR
Director ceased
VIVEK GUPTA
Director ceased
SUYOG JAIN
Director ceased
RAJINDER SINGH GUJRAL
23 Mar 2012
Director ceased
SUSHIL KUMAR SINGLA
Director ceased
PARMOD JAIN
29 Jan 2012
Securities allotted
820000 Equity Shares Without Differential Rights - 4.10 cr raised
05 Sep 2011
Securities allotted
1700000 Equity Shares Without Differential Rights - 8.50 cr raised
17 Dec 2010
Director ceased
ARUN JAIN
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 2 financial year(s).
3 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Oracle Biotech (India) Private Limited U24100MH2010PTC205503 Mumbai, Maharashtra, India
Zeni Tex Private Limited U17110GJ1990PTC014080 Surat, Gujarat, India
Ajay Labs Private Limited U24232TG2010PTC070564 Hyderabad, Telangana, India
Sante Sois Medicaments Private Limited U24233GJ2010PTC059787 Vadodara, Gujarat, India
Vinar Integration Limited U73100MH1998PLC115002 Mumbai, Maharashtra, India
Sln Pharmachem Pvt. Ltd. U24239MH2006PTC165825 Mumbai, Maharashtra, India
N.R.R. Laboratories Private Limited U24232TG2007PTC056244 Hyderabad, Telangana, India
Quester Capsules Private Limited U33111MH2011PTC214098 Nashik, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vardhman Life Sciences Private Limited before audits and certifications: compliance score 48/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vardhman Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Vardhman Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 43/100, distress signals and MSME payment-delay disclosures - know whether Vardhman Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Vardhman Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vardhman Life Sciences Private Limited an active company?

Vardhman Life Sciences Private Limited has MCA status “Active” with a compliance score of 48/100 (Caution Indicated).

Is Vardhman Life Sciences Private Limited financially healthy?

Vardhman Life Sciences Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Vardhman Life Sciences Private Limited?

Its overall Trust Score is 43/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vardhman Life Sciences Private Limited?

The ultimate holding entity is Vardhman Chemtech Limited. 3 active director(s) are on record.

Does Vardhman Life Sciences Private Limited have loans or charges against its assets?

4 open charge(s) are registered against its assets.

Is Vardhman Life Sciences Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 48/100 (Caution Indicated).

Is it risky to lend to Vardhman Life Sciences Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.